Search
for
Sort by
Research 361–390 of 725
- Poster session
- Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
- Mucocutaneous reactions to chemotherapy
- Estrogens and aging skin
- Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic mice.
- Lupus erythematosus: systemic and cutaneous manifestations
- Physiologic skin changes in pregnancy
- A Novel Point Mutation in the Ligand-Binding Domain (LBD) of the Human Glucocorticoid Receptor (hGR) Causing Generalized Glucocorticoid Resistance: The Importance of the C Terminus of hGR LBD in Conferring Transactivational Activity
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Hair Loss in Women
- Dermatophytosis in companion animals: A review
- Involvement of scalp and nails in lupus erythematosus
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Adrenal Disorders and the Paediatric Brain: Pathophysiological Considerations and Clinical Implications
- Pregnancy and the Skin
- Polycystic Ovarian Syndrome: Long-Term Health Consequences
- A Clinical Approach to Severe Insulin Resistance
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Frontal Fibrosing Alopecia: A Retrospective Analysis of 72 Patients from a German Academic Center
- Trichothiodystrophy with Dysmyelination and Central Osteosclerosis
- Association between Insulin Resistance and Cardiovascular Risk Factors in Polycystic Ovary Syndrome Patients
- Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects
- IMMUNOPATHOLOGY OF THE HUMAN HAIR FOLLICLE
- Common Dermatologic Conditions
- Syphilitic Alopecia: A Report of 5 Cases and a Review of the Literature
- Erosive Pustular Dermatosis of the Scalp Induced by Imiquimod
- Clinical picture of infectious syphilis
- ACUTE ZINC DEPLETION SYNDROME DURING PARENTERAL HYPERALIMENTATION
- Integrated Model of Care for Polycystic Ovary Syndrome
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases